Jun-2020
Hamilton’s Fusion Pharmaceuticals Inc. has increased its planned initial public offering on the Nasdaq by half and now hopes to raise up to US$230-million, the biotechnology developer said late Wednesday. The cancer drug developer filed Monday to go public, laying out plans to sell 8.35 million shares at US$14 to US$16 apiece, plus an option […]
Century Therapeutics today announced its acquisition of Empirica Therapeutics to leverage its iPSC-derived allogeneic cell therapies against glioblastoma (GBM). “We are pleased to welcome the Empirica team to the Century family. Their deep expertise and unique capabilities will allow us to accelerate efforts to develop iPSC derived immune effector cell products designed to treat and […]
Mar-2020
It doesn’t look that different from the other houses on Whitton Road in Westdale. Two-and-a-half storeys. A bay window. Some mock Tudor stylings. You might think a young family or a bunch of students live there. The smart home is part of a larger research effort by the McMaster Institute for Research on Aging (MIRA), […]
Triumvira Immunologics, Inc. (Triumvira), a Hamilton-based private, clinical-stage biopharmaceutical company developing a novel platform for engineering T-cells to attack cancers, today announced that the U.S. Food & Drug Administration (FDA) has granted Fast Track designation for its novel T-cell therapy product TAC01-CD19 in patients with relapsed or refractory Diffuse Large B-Cell Lymphoma (DLBCL) after at […]
Oct-2019
Contributing to the latest round of Mariner Endosurgery, Bay Area Health Trust shows strategic support for local health care businesses and ecosystem. HAMILTON, Ontario — Bay Area Health Trust (bayareahealthtrust.com), a Hamilton, Ontario based company that operates life science businesses with the goal of returning value to its beneficiaries including Hamilton Health Sciences announced it […]
VoxNeuro is excited to announce that the company will receive up to CA$249,000 in research and development funding from the National Research Council of Canada Industrial Research Assistance Program (NRC IRAP). Obtaining NRC IRAP funding not only serves as recognition for VoxNeuro’s focus on innovation, but will serve as a catalyst for the company’s continued […]
Five professors of the Faculty of Health Sciences have been elected fellows of the Canadian Academy of Health Sciences, considered one of the highest honours for members of the country’s health sciences community. Click here for the full article They have all been chosen through peer review for their demonstrated leadership, creativity, distinctive competencies, and […]
Since it was conceived, Versant Ventures has provided enabling support for the design and launch of an independent new venture capital and growth equity investment firm dedicated to the medtech sector. Today Vensana Capital debuted with the closing of its inaugural fund, Vensana Capital I, with $225 million in committed capital. The fund was oversubscribed, […]
Aug-2019
Thank you again to all who participated in the inaugural Future of Health Summit 2019 presented by Hamilton Health Sciences. HHS would also like to thank the delegates who provided their valuable feedback. We have summarized our reflections in the attached Future of Health (FOH) Summit Report 2019
Proposed Ontario Health Teams will transform how local care is provided under sweeping changes coming into effect as part of Conservative health care reform Hamilton and Burlington organizations want to be among the first to adopt a major overhaul of the health care system by the Progressive Conservative government. Health and social service agencies have banded together […]